SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

BRIEF-AIM ImmunoTech Completes And Closes ATM Facility, Current Capital Expected To Meet Needs For Current Clinical Trials

· 02/05/2021 07:01
BRIEF-AIM ImmunoTech Completes And Closes ATM Facility, Current Capital Expected To Meet Needs For Current Clinical Trials

- AIM ImmunoTech Inc AIM.A:

  • AIM IMMUNOTECH COMPLETES AND CLOSES ATM FACILITY; CURRENT CAPITAL EXPECTED TO MEET NEEDS FOR CURRENT CLINICAL TRIALS

  • AIM IMMUNOTECH - BELIEVES HAS ADEQUATE FUNDS TO MEET ANTICIPATED OPERATIONAL CASH NEEDS,FUND CURRENT CLINICAL TRIALS OVER ABOUT NEXT 24 MONTHS

Source text for Eikon: ID:nGNX7WyJgf

Further company coverage: AIM.A


((Reuters.Briefs@thomsonreuters.com;))